CRON vs. MTSR, ACAD, MOR, RXRX, XENE, AMRX, CPRX, HCM, BHC, and NAMS
Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Metsera (MTSR), ACADIA Pharmaceuticals (ACAD), MorphoSys (MOR), Recursion Pharmaceuticals (RXRX), Xenon Pharmaceuticals (XENE), Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), HUTCHMED (HCM), Bausch Health Companies (BHC), and NewAmsterdam Pharma (NAMS). These companies are all part of the "pharmaceutical products" industry.
Cronos Group vs.
Cronos Group (NASDAQ:CRON) and Metsera (NASDAQ:MTSR) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.
Metsera has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Metsera's return on equity of 0.00% beat Cronos Group's return on equity.
Cronos Group presently has a consensus target price of $3.00, indicating a potential upside of 62.60%. Metsera has a consensus target price of $47.00, indicating a potential upside of 61.51%. Given Cronos Group's higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Metsera.
8.7% of Cronos Group shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Metsera has lower revenue, but higher earnings than Cronos Group.
In the previous week, Cronos Group had 5 more articles in the media than Metsera. MarketBeat recorded 6 mentions for Cronos Group and 1 mentions for Metsera. Metsera's average media sentiment score of 0.45 beat Cronos Group's score of 0.12 indicating that Metsera is being referred to more favorably in the news media.
Cronos Group received 460 more outperform votes than Metsera when rated by MarketBeat users. However, 100.00% of users gave Metsera an outperform vote while only 61.13% of users gave Cronos Group an outperform vote.
Summary
Metsera beats Cronos Group on 7 of the 13 factors compared between the two stocks.
Get Cronos Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cronos Group Competitors List
Related Companies and Tools
This page (NASDAQ:CRON) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy CRON Stock Free CRON Stock Alerts